PROTOCOLOS CLÍNICOS E DIRETRIZES TERAPÊUTICAS

Distonias Focais e Espasmo Hemifacial Distonias Focais e Espasmo Hemifacial 40. Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2005;(1):CD003633. 41. Greene P, Kang U, Fahn S, Brin M, Moskowitz C, Flaster E. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology. 1990;40(8):1213-8. 42. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990;53(8):633-9. 43. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology. 1990;40(2):277-80. 44. Anderson TJ, Rivest J, Stell R, Steiger MJ, Cohen H, Thompson PD, et al. Botulinum toxin treatment of spasmodic torticollis. J Royal Soc Med. 1992;85(9):524-9. 45. Tsui JK, Bhatt M, Calne S, Calne DB. Botulinum toxin in the treatment of writer’s cramp: a double blind study. Neurology. 1993;43(1):183-5. 46. Yoshimura DM, Aminoff MJ, Olney RK. Botulinum toxin therapy for limb dystonias. Neurology. 1992;42(3 Pt 1):627-30. 47. Cole R, Hallett M, Cohen LG. Double-blind trial of botulinum toxin for treatment of focal hand dystonia. Mov Disord. 1995;10(4):466-71. 48. Karp BI, Cole RA, Cohen LG, Grill S, Lou JS, Hallett M. Long-term botulinum toxin treatment of focal hand dystonia. Neurology. 1994;44(1):70-6. 49. Stell R, Thompson PD, Marsden CD. Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry. 1988;51(7):920-3. 50. Moore AP, Blumhardt LD. A double blind trial of botulinum toxin “A” in torticollis, with one year follow up. J Neurol Neurosurg Psychiatry. 1991;54(9):813-6. 51. Picon PD, Guarany FC, Socal MP, Leal MP, Laporte EA, Schestatsky P, et al. Implementation of Brazilian guidelines for botulinum toxin: a three-year follow-up of a cost-reduction strategy in the public health system of Rio Grande do Sul, Brazil. Oral presentation of the 4th Health Technology Assessment International Annual Meeting; 2007 Jun 17-20; Barcelona, Spain. 193